2024-03-18 10:02:54 ET
Summary
- US providers for kidney dialysis and renal solutions, such as DaVita Inc. and Novo Nordisk, have seen significant gains in the past year.
- DaVita's decision to expand its renal care operations in Latin America, particularly in Brazil, Colombia, Ecuador, and Chile, will help grow revenues and establish a foothold outside of the US.
- DaVita's focus on home-based dialysis and hospital in-patient hemodialysis needs improvement, as these areas contribute less to revenue compared to outpatient dialysis services.
Read the full article on Seeking Alpha
For further details see:
DaVita Stock Is A Hold As It Expands In Latin America